你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 类型 | 题目 | 来源 | 阅读全文 |
|---|---|---|---|
| Consultation Documents | WHO points to consider in continuous manufacturing of pharmaceutical products | WHO Drug Information,2025,39,1 | 查看 |
| Consultation Documents | Development of paediatric medicines: points to consider in formulation | WHO Drug Information,2025,39,1 | 查看 |
| Consultation Documents | Ethambutol dihydrochloride tablets (ethambutoli dihydrochloridi compressi) | WHO Drug Information,2025,39,1 | 查看 |
| Consultation Documents | Aminosalicylate sodium delayed-release tablets (aminosalicylati natrii compressi ad tardatam liberationem) | WHO Drug Information,2025,39,1 | 查看 |
| Consultation Documents | Aminosalicylate sodium dihydrate (aminosalicylatum natricum dihydricus) | WHO Drug Information,2025,39,1 | 查看 |
| International Nonproprietary Names (INN) | Recommended INN List No. 93 | WHO Drug Information,2025,39,1 | 查看 |
| International Nonproprietary Names (INN) | Proposed INN List No. 132 | WHO Drug Information,2024,38,4 | 查看 |
| ATC/DDD Classification | ATC/DDD Classification (Temporary) | WHO Drug Information,2024,38,4 | 查看 |
| Pharmaceutical News | Potency Testing of Whole-Cell Pertussis-Containing Vaccines: Results of Multilaboratory Assessment of the Pertussis Serological Potency Test | WHO Drug Information,2024,38,4 | 查看 |
| Pharmaceutical News | BCS-Based Biowaiver Monograph for Hydrochlorothiazide | WHO Drug Information,2024,38,4 | 查看 |
| Pharmaceutical News | Quality of Immediate Release Solid Oral Hydrochlorothiazide Tablets in South Africa | WHO Drug Information,2024,38,4 | 查看 |
| Pharmaceutical News | World Health Organization External Quality Assurance Scheme – Phase 11 | WHO Drug Information,2024,38,4 | 查看 |
| Pharmaceutical News | Establishment of the Specific Absorbance Values for Albendazole and Atazanavir Sulfate and the Application thereof in the QC Testing of Medicines | WHO Drug Information,2024,38,4 | 查看 |
| Regulatory News | 19th International Conference of Drug Regulatory Authorities (ICDRA) - Recommendations for medical products | WHO Drug Information,2024,38,4 | 查看 |
| ATC/DDD Classification | ATC/DDD Classification (Final) | WHO Drug Information,2024,38,4 | 查看 |
| International Nonproprietary Names (INN) | Recommended INN List No. 92 | WHO Drug Information,2024,38,3 | 查看 |
| Consultation Documents | Good practices of national regulatory authorities in implementing the collaborative registration procedures for medical products | WHO Drug Information,2024,38,3 | 查看 |
| International Nonproprietary Names (INN) | Proposed INN List N. 131 | WHO Drug Information,2024,38,2 | 查看 |
| ATC/DDD Classification | ATC/DDD Classification (Temporary) | WHO Drug Information,2024,38,1 | 查看 |
| International Nonproprietary Names (INN) | Recommended INN List N. 91 | WHO Drug Information,2024,38,1 | 查看 |
